DexCom Inc. (DXCM)

168.11
4.50 2.80
NASDAQ : Health Technology
Prev Close 163.59
Open 163.44
Day Low/High 162.47 / 169.46
52 Wk Low/High 105.05 / 167.66
Volume 1.16M
Avg Volume 1.02M
Exchange NASDAQ
Shares Outstanding 91.19M
Market Cap 14.93B
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Go-Go Growth: Cramer's 'Mad Money' Recap (Tuesday 7/23/19)

Go-Go Growth: Cramer's 'Mad Money' Recap (Tuesday 7/23/19)

Jim Cramer says higher sales, higher prices, and demand from emerging markets seem to be fueling a return to the days of great senior growth stocks.

Pfizer, eBay, Cloudera: 'Mad Money' Lightning Round

Pfizer, eBay, Cloudera: 'Mad Money' Lightning Round

Jim Cramer weighs in on Pfizer, eBay, Cloudera, Cadence Systems, CRISPR Therapeutics, Moderna, Tandem Diabetes Care, and more.

Dexcom Schedules Second Quarter 2019 Earnings Release And Conference Call For July 31, 2019 At 4:30 P.m. Eastern Time

Dexcom Schedules Second Quarter 2019 Earnings Release And Conference Call For July 31, 2019 At 4:30 P.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2019 financial results after market close on Wednesday, July 31, 2019.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMEH, ATLC, DXCM, FBHS, HRI, OPOF Downgrades: PRSC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Dexcom Looks Like It Can Finally Break Out on the Topside

Dexcom Looks Like It Can Finally Break Out on the Topside

Let's check the charts and indicators on the glucose-monitoring company.

The Barbell Economy: Cramer's 'Mad Money' Recap (Thursday 6/13/19)

The Barbell Economy: Cramer's 'Mad Money' Recap (Thursday 6/13/19)

Jim Cramer looks at retail, specifically the companies that are doing well for working-class Americans, and those that cater to high-end customers -- a 'barbell economy,' he says.

Dexcom And Companion Medical Announce Collaboration To Integrate Dexcom CGM Data And InPen™ Insulin Data

Dexcom And Companion Medical Announce Collaboration To Integrate Dexcom CGM Data And InPen™ Insulin Data

DexCom, Inc. (NASDAQ:DXCM) and Companion Medical, Inc.

Dexcom Announces Upcoming Conference Presentation

Dexcom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company...

One-Two Punch: Cramer's 'Mad Money' Recap (Tuesday 5/7/19)

One-Two Punch: Cramer's 'Mad Money' Recap (Tuesday 5/7/19)

Jim Cramer's worried the market could reel from the tariff increases and a disappointing Uber IPO. He says investors need to brace for the possibilities.

Starbucks, DexCom, HealthEquity: 'Mad Money' Lightning Round

Starbucks, DexCom, HealthEquity: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Starbucks, DexCom, HealthEquity, Turning Point Brands, Tilray, CVS Health, Timken and more.

Dexcom Reports First Quarter 2019 Financial Results

Dexcom Reports First Quarter 2019 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2019.

DexCom, HCA Healthcare, Tractor Supply: 'Mad Money' Lightning Round

DexCom, HCA Healthcare, Tractor Supply: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at DexCom, HCA Healthcare, Tractor Supply, Sarepta Therapeutics, The Blackstone Group, HNI Corp. and more.

Investing's Not a Game: Cramer's 'Mad Money' Recap (Thursday 4/25/19)

Investing's Not a Game: Cramer's 'Mad Money' Recap (Thursday 4/25/19)

Jim Cramer says it's the start CNBC's annual Stock Draft Contest, but he cautions Mad Money viewers that although investing can be fun, it requires discipline and doing your homework.

A Telecom Supplier, an Appliance Maker and Other Stocks That Look Good Short

FNV, NOK, HBB, DXCM and MG all recently were downgraded by TheStreet's Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ESTE, PAGP, SJT, SPH, VOYA Downgrades: CPLG, DXCM, EVOL, FNV, RPM, TCPC Initiations: SECO, SPRO Read on to get TheStreet Quant Ratings' detailed report:

Dexcom Schedules First Quarter 2019 Earnings Release And Conference Call For May 1, 2019 At 4:30 P.m. Eastern Time

Dexcom Schedules First Quarter 2019 Earnings Release And Conference Call For May 1, 2019 At 4:30 P.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2019 financial results after market close on Wednesday, May 1, 2019.

What More Do They Want?: Cramer's 'Mad Money' Recap (Monday 3/25/19)

What More Do They Want?: Cramer's 'Mad Money' Recap (Monday 3/25/19)

Apple couldn't do much to hold back the bears today, but Jim Cramer says the company's services segment is the most important thing and he's more than happy with it.

Jim Cramer: Blockbuster Ideas That I Know Would Move Apple's Needle

Jim Cramer: Blockbuster Ideas That I Know Would Move Apple's Needle

What would the people who help determine AAPL's stock price really want?

Jim Cramer Won't Buy Apple Stock at Current Prices Unless the Company Does This

Jim Cramer Won't Buy Apple Stock at Current Prices Unless the Company Does This

The stock is just too expensive here ... unless the company buys these two medical-devices companies.

Disrupt or Be Disrupted: Cramer's 'Mad Money' Recap (Wednesday 3/13/19)

Disrupt or Be Disrupted: Cramer's 'Mad Money' Recap (Wednesday 3/13/19)

Disruptors are among the biggest winners, says Jim Cramer. Companies like Apple and Kraft Heinz need to re-imagine their companies in bold, meaningful and even radical ways.

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

In this day and age, companies must be 'disruptors' or get left in the dust.

A Technical Strategy for Tandem Diabetes Care

A Technical Strategy for Tandem Diabetes Care

Are we late to the game with the stock up so much?

Your Game Plan: Cramer's 'Mad Money' Recap (Friday 3/1/19)

Your Game Plan: Cramer's 'Mad Money' Recap (Friday 3/1/19)

Jim Cramer has your game plan for next week: Keep a sharp eye out for the Fed and the employment data.

Dexcom Announces Upcoming Conference Presentation

Dexcom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company...

Dexcom G6® CGM System Receives Health Canada Approval

Dexcom G6® CGM System Receives Health Canada Approval

VANCOUVER, Feb. 22, 2019 /CNW/ - Dexcom, Inc.

Dexcom Reports Fourth Quarter And Fiscal Year 2018 Financial Results

Dexcom Reports Fourth Quarter And Fiscal Year 2018 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2018.

Dexcom Schedules Fourth Quarter And Full Year 2018 Earnings Release And Conference Call For February 21, 2019 At 4:30 P.m. Eastern Time

Dexcom Schedules Fourth Quarter And Full Year 2018 Earnings Release And Conference Call For February 21, 2019 At 4:30 P.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2018 financial results after market close on Thursday, February 21, 2019.

Tumultuous, but Positive: Cramer's 'Mad Money' Recap (Friday 1/11/19)

Tumultuous, but Positive: Cramer's 'Mad Money' Recap (Friday 1/11/19)

This will be the craziest reporting season we've seen in ages, says Jim Cramer. He's got your game plan for next week.

TheStreet Quant Rating: C (Hold)